Drug intelligence / Profile preview

peptide 5

Development stage
Preclinical
Lead developer
CoDa Therapeutics
Modality
Peptides
Administration
Intravitreal, Intrathecal, Topical, Intravenous
01

Overview

Peptide 5 is a synthetic dodecapeptide that mimics a specific sequence within the second extracellular loop (EL2) of the Gap junction alpha-1 protein, commonly known as Connexin 43 (Cx43). It functions primarily as a selective blocker of Cx43 hemichannels. During conditions of cellular stress, inflammation, or injury, Cx43 hemichannels—which are normally closed—can open abnormally, leading to the release of pro-inflammatory molecules such as ATP and glutamate into the extracellular space, thereby exacerbating tissue damage and neuroinflammation. Peptide 5 binds to the extracellular loop of the connexin protein, preventing the opening of these hemichannels and the subsequent inflammatory cascade. Notably, at low concentrations, Peptide 5 selectively inhibits hemichannels without disrupting established gap junction communication between cells, although it may inhibit gap junctions at higher concentrations. It has been investigated for its neuroprotective and anti-inflammatory potential in treating spinal cord injury, stroke, and various retinal diseases, including age-related macular degeneration and diabetic retinopathy.

Other names
Cx43 mimetic peptide 5Cx-43 mimetic peptide 5Cx 43 mimetic peptide 5Connexin 43 mimetic peptide 5Connexin43 mimetic peptide 5Connexin-43 mimetic peptide 5VDCFLSRPTEKT
02

Targets

GJA1 (Connexin43 Hemichannel)

Beyond the preview

Go deeper on peptide 5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on peptide 5.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call